Literature DB >> 1736295

Profound specific suppression by antigen of persistent IgM, IgG, and IgE antibody production.

H M Dintzis1, R Z Dintzis.   

Abstract

Ongoing, high-titer T-cell-dependent immune responses in adult mice, consisting of IgM, IgG, and IgE anti-fluorescein antibodies, can be specifically and substantially reduced (90-99%) when the mice are injected with appropriate doses of fluoresceinated dextran of defined molecular weight and hapten valence. This suppressive form of the antigen is nontoxic and specific, as responses to other antigens are unaffected. The suppression is long lasting and reduces high-affinity antibodies most markedly. Moreover, plasma cell secretion of specific antibody is virtually eliminated. This demonstrates that the reduction in antibody titer is not simply due to masking of serum antibody by the suppressive polymer. The results are discussed with reference to proposed models of B-cell and T-cell tolerance. Extension of these findings to disease-related immunogens may yield effective antigen-specific treatments of human allergy and autoimmune diseases.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1736295      PMCID: PMC48396          DOI: 10.1073/pnas.89.3.1113

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  34 in total

1.  IMMUNOLOGICAL UNRESPONSIVENESS TO PROTEIN ANTIGENS IN RABBITS. I. THE DURATION OF UNRESPONSIVENESS FOLLOWING A SINGLE INJECTION AT BIRTH.

Authors:  J H HUMPHREY
Journal:  Immunology       Date:  1964-07       Impact factor: 7.397

2.  Studies on the mechanism of the immunological paralysis induced in mice by pneumococcal polysaccharides.

Authors:  L D FELTON; G KAUFFMANN; B PRESCOTT; B OTTINGER
Journal:  J Immunol       Date:  1955-01       Impact factor: 5.422

Review 3.  Acquisition of immunologic self-tolerance.

Authors:  R H Schwartz
Journal:  Cell       Date:  1989-06-30       Impact factor: 41.582

Review 4.  Immunologic tolerance: collaboration between antigen and lymphokines.

Authors:  G J Nossal
Journal:  Science       Date:  1989-07-14       Impact factor: 47.728

Review 5.  Self tolerance in the B-cell repertoire.

Authors:  A Basten; R Brink; P Peake; E Adams; J Crosbie; S Hartley; C C Goodnow
Journal:  Immunol Rev       Date:  1991-08       Impact factor: 12.988

6.  The interaction of nominal antigen with T cell antigen receptors. I. Specific binding of multivalent nominal antigen to cytolytic T cell clones.

Authors:  R F Siliciano; A D Keegan; R Z Dintzis; H M Dintzis; H S Shin
Journal:  J Immunol       Date:  1985-08       Impact factor: 5.422

Review 7.  Molecular aspects of B-lymphocyte activation.

Authors:  A L DeFranco
Journal:  Annu Rev Cell Biol       Date:  1987

8.  The immunogenicity of soluble haptenated polymers is determined by molecular mass and hapten valence.

Authors:  R Z Dintzis; M Okajima; M H Middleton; G Greene; H M Dintzis
Journal:  J Immunol       Date:  1989-08-15       Impact factor: 5.422

Review 9.  Drug allergy.

Authors:  M S Blaiss; R D deShazo
Journal:  Pediatr Clin North Am       Date:  1988-10       Impact factor: 3.278

10.  Antigen valence determines the binding of nominal antigen to cytolytic T cell clones.

Authors:  R F Siliciano; R M Colello; A D Keegan; R Z Dintzis; H M Dintzis; H S Shin
Journal:  J Exp Med       Date:  1985-08-01       Impact factor: 14.307

View more
  6 in total

1.  Removal of anti-Galalpha1,3Gal xenoantibodies with an injectable polymer.

Authors:  Andreas G Katopodis; Richard G Warner; Rudolf O Duthaler; Markus B Streiff; Armin Bruelisauer; Olivier Kretz; Birgit Dorobek; Elke Persohn; Hendrik Andres; Alain Schweitzer; Gebhard Thoma; Willy Kinzy; Valerie F J Quesniaux; Emanuele Cozzi; Hugh F S Davies; Rafael Mañez; David White
Journal:  J Clin Invest       Date:  2002-12       Impact factor: 14.808

2.  Limiting dilution analysis of CD4 T-cell cytokine production in mice administered native versus polymerized ovalbumin: directed induction of T-helper type-1-like activation.

Authors:  R S Gieni; X Yang; A Kelso; K T Hayglass
Journal:  Immunology       Date:  1996-01       Impact factor: 7.397

3.  Anti-immunoglobulin E antibody treatment blocks histamine release and tissue contraction in sensitized mice.

Authors:  M Haak-Frendscho; R Saban; R L Shields; P M Jardieu
Journal:  Immunology       Date:  1998-05       Impact factor: 7.397

4.  Protection of mice against Salmonella typhimurium with an O-specific polysaccharide-protein conjugate vaccine.

Authors:  D C Watson; J B Robbins; S C Szu
Journal:  Infect Immun       Date:  1992-11       Impact factor: 3.441

5.  Administration of an anti-IgE antibody inhibits CD23 expression and IgE production in vivo.

Authors:  M Haak-Frendscho; K Robbins; R Lyon; R Shields; J Hooley; M Schoenhoff; P Jardieu
Journal:  Immunology       Date:  1994-06       Impact factor: 7.397

6.  Inhibition or activation of human T cell receptor transfectants is controlled by defined, soluble antigen arrays.

Authors:  D E Symer; R Z Dintzis; D J Diamond; H M Dintzis
Journal:  J Exp Med       Date:  1992-11-01       Impact factor: 14.307

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.